Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to compare the uterus tissue of women who receive an intrauterine system to treat their endometrial hyperplasia with the uterine tissue of women who receive megestrol acetate to treat their hyperplasia. While both methods are commonly used in practice, investigators would like to see what effects each treatment has on uterine tissue.


Clinical Trial Description

Primary Objective: To determine if Levonorgestrel-releasing intrauterine system is of equal efficacy to the standard systemic progestin therapy (megestrol acetate) based on endometrial sampling at 6 months after randomization. Non-inferiority analysis. Secondary Objective(s): - To determine the safety of each treatment modality. - Determine the feasibility of transvaginal ultrasound to predict treatment response. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04897217
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Withdrawn
Phase Phase 3
Start date June 30, 2023
Completion date November 2026

See also
  Status Clinical Trial Phase
Completed NCT05378152 - Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity N/A
Withdrawn NCT00123175 - Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD) Phase 1/Phase 2
Completed NCT02100137 - Women With Asymptomatic Endometrial Hyperplasia N/A
Completed NCT00242710 - Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women Phase 3
Not yet recruiting NCT04191603 - TWO DÄ°FFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY N/A
Completed NCT03032848 - Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients Phase 4
Completed NCT00339651 - Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Recruiting NCT01234818 - Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 Phase 2
Recruiting NCT04362046 - Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia N/A
Active, not recruiting NCT05257057 - Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
Completed NCT00883662 - Mirena Observational Program N/A
Completed NCT01499602 - Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women N/A
Completed NCT01074892 - A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia Phase 4
Not yet recruiting NCT05903131 - A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Phase 2
Not yet recruiting NCT05829460 - Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Phase 2
Recruiting NCT03176992 - Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding Phase 2
Not yet recruiting NCT00919919 - Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen Phase 2
Recruiting NCT03207061 - Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? N/A
Recruiting NCT03207126 - Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? N/A
Completed NCT03207074 - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? N/A